osaühing NÕO APTEEK

Active Registry code 10039397 OÜ Nõo alevik Registered 5 Jun 1996

osaühing NÕO APTEEK is a OÜ based in Nõo alevik, registry code 10039397, status: active. Main activity: Retail sale of pharmaceutical products. According to EMTA, turnover for Q3 2026 was €83 892 with employees.

Turnover

83 892 €

↑ 0.3% vs Q2 2026

State taxes

5 672 €

↓ 4.7% vs Q2 2026

Labour taxes

5 128 €

↑ 11.3% vs Q2 2026

Employees

—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Retail trade · EMTAK 47

Turnover · Q3 2026 83 892 €

above 73% of companies

industry median 23 652 € · companies in the industry: 7 652
Revenue · 2025 337 867 €

above 86% of companies

industry median 16 974 € · companies in the industry: 13 500
Net profit margin · 2025 1.6 %

above 51% of companies

industry median 1.3 % · companies in the industry: 9 480

Taxes and turnover

Q4 2023 – Q3 2026

Turnover, € Q3 2026: 83 892 € · +0.3% vs Q2 2026 · industry median 23 652 € · above 73% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q3 2026: 5 672 € · −4.7% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	83 892	5 672	5 128	—
Q2 2026	83 626	5 949	4 608	—
Q1 2026	87 575	6 423	4 787	—
Q4 2025	94 372	10 391	5 128	—
Q3 2025	81 734	6 102	5 128	—
Q2 2025	92 442	6 444	5 128	—
Q1 2025	82 009	5 863	4 479	—
Q4 2024	91 132	8 470	4 918	—
Q3 2024	85 747	7 158	4 421	—
Q2 2024	87 805	5 782	3 970	—
Q1 2024	91 049	5 132	3 456	—
Q4 2023	92 008	6 729	3 811	—
Q3 2023	83 654	4 406	3 134	—
Q2 2023	84 446	4 916	3 134	—
Q1 2023	84 325	4 753	3 134	—
Q4 2022	84 264	10 894	3 134	—
Q3 2022	72 896	7 199	3 499	—
Q2 2022	78 974	3 852	2 457	—
Q1 2022	89 387	4 059	2 457	—

Financials by year

2016 – 2025

Revenue, € thousand 2025: 337 867 € · +1.2% vs 2024 · industry median 16 974 € · above 86% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 5 246 € · −57.1% vs 2024 · industry median 0 € · above 80% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 1.6 % · −2.1 pp vs the year before · industry median 1.3 % · above 51% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 96 424 € · −1.7% vs 2024

Equity, € 2025: 45 856 € · −17.5% vs 2024

Employees 2025: 1 · +0.0% vs 2024 · industry median 2 · above 5% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	337 867	5 246	45 712	96 424	45 856	1
2024	334 006	12 234	38 679	98 081	55 610	1
2023	321 267	22 179	30 536	105 835	63 376	1
2022	329 549	14 180	27 238	99 477	51 197	1
2021	340 678	25 966	23 940	111 820	77 017	1
2020	293 096	19 043	21 497	95 111	66 051	1
2019	253 831	15 374	20 276	78 429	57 008	1
2018	—	—	—	—	—	1
2017	—	—	—	—	—	1
2016	—	—	—	—	—	1
2015	—	—	—	—	—	1
2014	—	—	—	—	—	1
2013	—	—	—	—	—	1
2012	—	—	—	—	—	1
2011	—	—	—	—	—	1
2010	—	—	—	—	—	1
2009	—	—	—	—	—	1
2008	—	—	—	—	—	2
2007	—	—	—	—	—	2
2006	—	—	—	—	—	2
2005	—	—	—	—	—	2
2004	—	—	—	—	—	2
2003	—	—	—	—	—	2
2002	—	—	—	—	—	2
2001	—	—	—	—	—	2
2000	—	—	—	—	—	2
1999	—	—	—	—	—	2

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin

1.5 %

Net profit / revenue

Return on equity (ROE)

11.4 %

Net profit / equity

Return on assets (ROA)

5.4 %

Net profit / assets

Equity ratio

47.6 %

Equity / assets

Debt ratio

52.4 %

Liabilities / assets

Current ratio

1.91

Current assets / current liabilities

Revenue per employee

357 335 €

Revenue / average full-time employees

Labour cost per employee per month

3 809 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	22 Jun 2026	Company’s own	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	20 Jun 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	18 Jun 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	28 Jun 2023	Company’s own	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	28 Jun 2022	Company’s own	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	15 Jun 2021	Company’s own	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	27 Oct 2020	Company’s own	e-Äriregister

Board

Anne Saar
Board member (manager) · since 5 Jun 1996

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Anne Saar
Natural person · 2 556 €

100%

Beneficial owners

Anne Saar
Direct ownership · since 11 Jun 2019

Founders and other persons

No other persons.

Activities (EMTAK)

47731Retail sale of pharmaceutical products Main

Rulings 5

All rulings (PDF)

Rulings
Number, date	Title	State	Document
Ä 20000729 / 7 1 Sep 2023	Amendment entry	In force 1 Sep 2023	PDF
Ä 20000729 / 6 18 Jan 2018	Amendment entry	In force 18 Jan 2018	PDF
Ä 20000729 / 5 3 Dec 2017	Amendment entry	In force 3 Dec 2017	PDF
Ä 20000729 / 4 11 Apr 2011	Amendment entry	In force 11 Apr 2011	PDF
Ä 729 / 3 28 Dec 2008	Deletion of activities from the registry card	In force 28 Dec 2008	PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data